What Is a FTM? Female to Male Identity Explained

FTM stands for “female to male” and describes a person who was assigned female at birth but identifies and lives as male. The term has been used in medical, legal, and community contexts for decades, though many people today prefer “trans man” or “transmasculine” as less clinical-sounding alternatives. Understanding what FTM actually involves goes well beyond a dictionary definition, because it touches on medical decisions, legal paperwork, social relationships, and day-to-day life in ways that vary enormously from person to person.

What FTM Actually Means in Everyday Life

At its core, being FTM means that the gender you were labeled with at birth based on your anatomy does not match who you know yourself to be. A trans man may pursue medical steps like hormone therapy or surgery, but many do not, and neither choice makes someone more or less legitimately FTM. The label describes an identity, not a checklist of procedures. Some trans men transition socially first, changing their name, pronouns, and presentation, and decide later whether medical intervention feels right for them. Others start hormones early and pursue surgeries. Still others settle into a social transition alone and find that sufficient.

The experience is not a modern invention. Anthropological and historical records document people living outside the gender they were assigned at birth across six continents and spanning roughly five millennia. Concepts of transitioning or identifying as neither strictly male nor strictly female appear in the belief systems and cultural practices of societies worldwide, long before Western medicine created formal terminology for it.¹

Who Is Seeking Transition, and How the Numbers Have Shifted

For a long time, the assumption in clinical settings was that trans women (male to female) far outnumbered trans men. That assumption has been overturned. Data from a large U.S. clinic showed that over the past twenty-five years, the proportion of FTM individuals starting hormone therapy has risen steadily and is now roughly equal to the proportion of MTF individuals. The average age at which people begin hormones has also dropped, falling below 30 in recent years.² That shift reflects both greater visibility and reduced barriers to care rather than any sudden spike in transgender identity itself.

Testosterone Therapy and What It Changes

Testosterone is the cornerstone of medical masculinization for trans men who choose hormone therapy. It drives a range of physical changes, some of which begin within weeks and others that develop over months or years. The most commonly noticed early changes include a deeper voice, increased body and facial hair growth, redistribution of body fat toward a more typically male pattern, and increased muscle mass. Menstruation typically stops within the first several months.

Voice Changes

Voice deepening is one of the changes trans men care about most, because a voice that reads as male can make an enormous difference in daily social interactions. Research tracking transmasculine individuals on testosterone found that the average speaking pitch drops significantly within the first three to six months and typically reaches the male reference range by about twelve months, with a group average around 125 Hz after a year of treatment.³ A longitudinal case study documented one individual’s speaking pitch falling from 183 Hz to 134 Hz, with the entire singing range shifting downward as well.⁴ The drop is permanent even if testosterone is later discontinued, because the vocal cords thicken irreversibly.

There is considerable variation between individuals, though. Some trans men find their voice settles at a pitch they are happy with; others feel it sounds strained or breathy during the transition period. Beyond pitch alone, testosterone also affects vocal quality measures like shimmer and the acoustic character of certain speech sounds.⁵ Pitch is the most obvious marker, but it is not the only thing that makes a voice sound masculine. Resonance, speech patterns, and articulation all play a role, which is why some trans men pursue voice training alongside or instead of relying on hormones alone.

Skin and Acne

Acne is one of the most common side effects of testosterone therapy for transmasculine individuals, and it can range from mild breakouts to severe, treatment-resistant cystic acne.⁶ For some, it is a minor inconvenience. For others, it becomes a genuine medical problem that requires dermatological treatment including, in severe cases, isotretinoin. Androgenic hair loss, the same male-pattern balding that affects cisgender men, can also develop over time. Survey research has found that dermatologists’ clinical preparedness for managing testosterone-induced acne and hair loss in trans men remains uneven, with objective knowledge gaps even among providers who report feeling comfortable treating these conditions.⁷

Sexual Function

Testosterone affects sexual function in several ways. Research involving trans men and gender diverse people assigned female at birth found that current testosterone use was linked to higher interest in sexual activity. However, it was also associated with more vaginal pain or discomfort during sexual activity, likely due to testosterone-driven vaginal atrophy. No clear association was found between testosterone use and satisfaction with sex life, lubrication, or orgasm pleasure.⁸ That mix of effects is important to understand going in, because the vaginal dryness and discomfort can often be managed with topical estrogen, but many trans men are unaware this is a common issue or are reluctant to bring it up with providers.

Surgical Options

Not every trans man pursues surgery, and among those who do, the range of procedures varies widely. The two broad categories are “top surgery” (chest masculinization) and “bottom surgery” (genital reconstruction), and they are typically treated as separate decisions rather than a package deal.

Top Surgery

Chest masculinization, commonly called top surgery, is the most frequently performed gender-affirming surgery for trans men. The most common technique for larger-chested individuals is a double-incision mastectomy with free nipple grafting. In a study of 72 such procedures, major complications requiring a return to the operating room occurred in a small minority of cases, most commonly hematomas. Minor complications like seromas and hypertrophic scars were treated conservatively. Nicotine use was associated with a significantly higher rate of hematoma.⁹ A separate study incorporating ultrasound-assisted liposuction into top surgery reported complication rates of about 12%, with high patient satisfaction and improved quality of life scores.¹⁰

For smaller-chested individuals, concentric circular or periareolar techniques can achieve masculinization with less visible scarring. Newer approaches, including axillary (armpit) access mastectomy, aim to further minimize scarring, though complication rates in early series have been somewhat higher, predominantly in the form of minor, reversible nipple skin changes. Patient satisfaction in one series of 48 patients was nonetheless very high.¹¹ Top surgery is often described by trans men as one of the most life-changing steps in their transition, frequently more so than hormones alone, because it eliminates the need for binding and allows comfort in everyday activities like swimming or wearing a t-shirt.

Bottom Surgery

Genital reconstruction for trans men is more complex and less commonly pursued than top surgery. The two main approaches are metoidioplasty, which releases and repositions the clitoris (which has typically enlarged on testosterone) to create a small phallus, and phalloplasty, which constructs a full-sized phallus using tissue grafted from another part of the body, most commonly the forearm.

Both procedures carry meaningful complication rates, especially when urethral lengthening is performed to allow standing urination. In a large series of 311 patients who underwent metoidioplasty or radial forearm free-flap phalloplasty, urethral fistulas developed in about 16% of metoidioplasty patients and 29% of phalloplasty patients. Strictures occurred in 6% and 18%, respectively. Over half of the phalloplasty fistulas resolved on their own, but surgical repair was needed in about 12% of metoidioplasty patients and 19% of phalloplasty patients.¹² A separate study looking at whether staging the procedures differently could reduce complications found that about 59% of patients in both groups needed at least one additional surgery for complications.¹³

These numbers are not meant to be discouraging. Surgeons and patients generally view phalloplasty and metoidioplasty as multi-stage processes where revisions are expected rather than unusual. What matters is that people going into these procedures understand the realistic timeline, which can stretch over a year or more and involve several surgeries, and plan accordingly.

Long-Term Health on Testosterone

One of the practical questions trans men and their doctors face is what testosterone does to cardiovascular risk, bone density, and metabolic health over the long haul.

On the cardiovascular front, the picture is reassuring but incomplete. A narrative review of recent literature, including meta-analyses and large cohort studies, concluded that while estrogen therapy appears to increase cardiovascular event risk in trans women, it remains unclear whether testosterone increases that risk in trans men.¹⁴ What is established is that testosterone shifts lipid profiles in directions that look less favorable on paper: HDL cholesterol (the “good” cholesterol) drops by roughly 16% within the first several months of therapy, and triglyceride levels can climb by about a quarter to a third over time.¹⁵ Whether those lipid shifts translate into more heart attacks and strokes over decades is the open question, and the answer depends on ongoing long-term follow-up studies that are still maturing.

Bone health is less concerning. Testosterone therapy generally maintains or promotes bone density in trans men, and short-term prospective trials have not found increased fracture rates.¹⁶ Some of testosterone’s bone effects are indirect, working through changes in lean mass and fat distribution rather than acting on bone cells directly.¹⁷ The practical takeaway is that trans men on testosterone do not appear to be at elevated risk for osteoporosis relative to their peers, though the evidence base is still relatively thin for people who have been on hormones for several decades.

Mental Health and the Role of Social Support

Gender dysphoria, the distress that comes from a mismatch between your body or social role and your gender identity, takes a real toll on mental health. A systematic review found that individuals who received gender-affirming interventions showed significant improvement in both mental health and body image acceptance.¹⁸ Among transgender and nonbinary youth specifically, those who had started puberty blockers or gender-affirming hormones had roughly 60% lower odds of depression and 73% lower odds of suicidality compared to those who had not, after adjusting for potential confounders.¹⁹

Medical transition is not the only factor, though. Family support turns out to be especially powerful. A study of nearly 700 transgender individuals found that family social support had the strongest relationship with lower anxiety and depression symptoms and was the only form of support independently linked to resilience after controlling for other types of support like friends and community.²⁰ Those with high support from both family and friends showed the best mental health outcomes across the board.

A larger longitudinal study of over 2,400 trans and nonbinary adults added a sobering wrinkle: while people in low-support profiles had clearly worse depression and PTSD symptoms, being in a higher-support profile did not necessarily buffer the ongoing harms of minority stress over time.²¹ In other words, support helps set a better baseline, but it does not erase the cumulative effect of discrimination, harassment, and systemic exclusion. That distinction matters for how families and communities think about their role: being supportive is genuinely protective, but it is not a substitute for broader societal change.

Legal Recognition and Why Paperwork Matters

Changing your name and gender marker on official documents might sound like mere bureaucracy, but research suggests it has measurable mental health effects. Trans people who updated the gender marker on both their passport and driver’s license had roughly half the odds of reporting emotional distress from gender-based mistreatment and substantially lower odds of anxiety and global psychiatric distress compared to those who had not changed either document. Updating one’s name on both documents showed similarly strong associations with lower depression and anxiety.²² Research from Australia has corroborated these patterns, finding that legal gender affirmation was correlated with lower psychological distress and increased gender euphoria.²³

The mechanism is intuitive once you think about it. Every time you hand over an ID that does not match your appearance or your name, you are forced into an outing situation. That might mean an awkward interaction at a pharmacy counter or a dangerous encounter with a bouncer or a police officer. Reducing the frequency of those moments reduces chronic stress. The legal landscape for name and gender marker changes varies enormously by jurisdiction, ranging from straightforward administrative processes to requirements for surgery or court orders, and that unevenness itself becomes a source of inequity.

Neuroscience and the Brain

A question that comes up repeatedly is whether there is anything biologically “different” about the brains of transgender individuals. The research here is early-stage and should be interpreted carefully, but brain imaging studies have found that trans men’s brains do not simply match either a typical female or typical male pattern. Instead, they show a mosaic: some regions that look characteristically feminine, others that look masculine, and still others described as “defeminized,” meaning they have moved away from a female-typical pattern without fully reaching a male-typical one.²⁴ The same general pattern, but in reverse, has been observed in trans women.

These findings are interesting, but they come with major caveats. Sample sizes in brain structure studies of transgender people have been small. The studies cannot tell us whether these differences are a cause of transgender identity or a consequence of it (or of the hormonal environment, social experiences, and other factors that differ between groups). And the idea that there are cleanly separable “male” and “female” brain structures is itself contested in broader neuroscience. Still, the research does push back against the oversimplified notion that being transgender is purely a social phenomenon with no biological correlates.

Detransition and Discontinuation

Detransition receives outsized media attention relative to how common it actually is. A systematic review looking at hormone discontinuation rates found that the proportion of people stopping gender-affirming hormone therapy ranged from about 2% to 10% across studies, though definitions of “detransition” and study designs varied widely.²⁵ One study in the U.S. military health system found a four-year hormone continuation rate of about 70% overall, with transmasculine individuals having a higher discontinuation rate than transfeminine individuals. That study could not determine why people stopped, and a 90-day gap in filling prescriptions was used as the threshold, which could capture logistical interruptions as easily as genuine detransition.²⁶

When detransition does occur, the reasons are often not what people assume. Among those who had detransitioned in one U.S. survey, over 80% cited at least one external factor, such as pressure from family or societal stigma. Only about 16% reported internal factors like fluctuations in or uncertainty about their gender identity.²⁷ In other words, most people who detransitioned did not stop identifying as trans; they stopped living as trans because the external costs became too high. That distinction is important because it reframes detransition primarily as a social problem rather than evidence that people were “wrong” about their identity.

Healthcare Access and Discrimination

Trans men face real barriers when trying to access routine healthcare, not just transition-related care. Survey data from the large U.S. Transgender Survey found that both trans women and trans men were more likely to postpone healthcare out of fear of discrimination and more likely to have experienced discrimination in healthcare settings compared to nonbinary respondents.²⁸ That avoidance pattern can delay treatment for conditions that have nothing to do with gender, from infections to cancer screenings, creating compounding health risks over time.

Trans men who still have a cervix need Pap smears. Trans men who still have ovaries may need monitoring for ovarian conditions. But walking into a gynecologist’s office when you look, sound, and identify as male is an experience that ranges from uncomfortable to hostile depending on the provider and the waiting room. Navigating these situations is a practical reality of FTM life that rarely appears in textbook descriptions of transition but occupies a lot of mental energy for the people living it.